3 Year Follow up Study of the IDEA Population

NCT ID: NCT03924973

Last Updated: 2025-03-06

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

93 participants

Study Classification

INTERVENTIONAL

Study Start Date

2019-04-17

Study Completion Date

2023-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The aim of this study is to assess the efficiency of early treatment for ASD children 5 years after initial treatment.

The early treatment implemented was 12 hours per week of ESDM versus treatment as usual during 2 years. This was done as an RCT, called IDEA. Children will now be included in IDEA-2 SCOLA, a three year follow up study.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

180 children with ASD, younger than 3 years old, were included in the IDEA RCT. Children were allocated to the ESDM treatment group or the treatment as usual group. The aim of IDEA-2 is to follow-up this population for 3 years after the initial 2 years of intervention, that is, 5 years after initial inclusion to IDEA.

Investigators hypothesize that children who received ESDM 12 hours per week will have a significant decrease of autism symptoms and will have a better scholastic level 5 years after initial inclusion to IDEA.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Autism

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

single blind
Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Outcome Assessors
randomization will follow that of the IDEA study

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Experimental group

Children below the age of 3 in this group received 2 years of ESDM intervention for 12 hours per week, and then treatment as usual for the 3 following years.

What is called "treatment as usual" is what the community can usually offer. That is what the control group in IDEA received.

In IDEA-2, both control and interventional group of IDEA will receive treatment as usual during 3 years.

Treatment as usual comprises of different types of interventions, such as speech pathology therapy, occupational therapy and other types of therapy more or less specific to ASD in the community.

Group Type EXPERIMENTAL

ESDM followed by treatment as usual

Intervention Type BEHAVIORAL

The intervention was ESDM, delivered by professionals, one therapist per child, 12 hours per week during 2 years.

Then, they will receive the treatment as usual during 3 years in this current follow-up study.

Precise description of the 2 years ESDM treatment can be found in the published protocol of IDEA.

What is called "treatment as usual" is what the community can usually offer. That is what the control group in IDEA received.

In IDEA-2, both control and interventional group of IDEA will receive treatment as usual during 3 years.

Treatment as usual comprises of different types of interventions, such as speech pathology therapy, occupational therapy and other types of therapy more or less specific to ASD in the community.

All the interventions received by the children will be monitored in IDEA-2. All different treatment approaches will be quantified (type, frequency, intensity and duration).

Control group

Children in this group received treatment as usual delivered in the community for the 2 years of IDEA.

Participants will still receive treatment as usual delivered in the community during IDEA-2, in the 3 years following IDEA.

Group Type OTHER

ESDM followed by treatment as usual

Intervention Type BEHAVIORAL

The intervention was ESDM, delivered by professionals, one therapist per child, 12 hours per week during 2 years.

Then, they will receive the treatment as usual during 3 years in this current follow-up study.

Precise description of the 2 years ESDM treatment can be found in the published protocol of IDEA.

What is called "treatment as usual" is what the community can usually offer. That is what the control group in IDEA received.

In IDEA-2, both control and interventional group of IDEA will receive treatment as usual during 3 years.

Treatment as usual comprises of different types of interventions, such as speech pathology therapy, occupational therapy and other types of therapy more or less specific to ASD in the community.

All the interventions received by the children will be monitored in IDEA-2. All different treatment approaches will be quantified (type, frequency, intensity and duration).

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

ESDM followed by treatment as usual

The intervention was ESDM, delivered by professionals, one therapist per child, 12 hours per week during 2 years.

Then, they will receive the treatment as usual during 3 years in this current follow-up study.

Precise description of the 2 years ESDM treatment can be found in the published protocol of IDEA.

What is called "treatment as usual" is what the community can usually offer. That is what the control group in IDEA received.

In IDEA-2, both control and interventional group of IDEA will receive treatment as usual during 3 years.

Treatment as usual comprises of different types of interventions, such as speech pathology therapy, occupational therapy and other types of therapy more or less specific to ASD in the community.

All the interventions received by the children will be monitored in IDEA-2. All different treatment approaches will be quantified (type, frequency, intensity and duration).

Intervention Type BEHAVIORAL

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Treatment as usual delivered in the community

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Inclusion in the initial IDEA trail
* Requiring less than 40 minutes travel to the assessment center

Exclusion Criteria

* Impossibility of coming in for assessment
* Exclusion from IDEA
Minimum Eligible Age

39 Months

Maximum Eligible Age

60 Months

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Hôpital le Vinatier

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

GEOFFRAY MARIE-MAUDE, PH

Role: PRINCIPAL_INVESTIGATOR

CH LE VINATIER

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Hopital Vinatier

Bron, , France

Site Status

Countries

Review the countries where the study has at least one active or historical site.

France

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2017-A02446-47

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.